Neuroscience thought leader joins Axol SAB

Axol CEO Yichen Shi said: “We are proud to have such an accomplished individual on board. Steve brings years of experience in plasticity and neurodegenerative research to the Axol team.” Cambridge stem cell technology pioneer, Axol Bioscience, has attracted a world-leading neuroscientist to its Scientific Advisory Board. Dr Steve Finkbeiner, famed for his work for a top university department in California, will guide Axol in expanding its range of induced pluripotent stem cell (iPSC)-derived neural cells and culture systems to ensure the company continues to bring innovative products to market. Dr Finkbeiner is renowned for his research in neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and Huntington’s, Parkinson’s and Alzheimer’s diseases. He is perhaps best known for his invention of a robotic imaging device that has helped to elucidate the…


Link to Full Article: Neuroscience thought leader joins Axol SAB